HPV infections and tonsillar carcinoma

Journal of Clinical Pathology

Volumn 57, Issue 5, 2004, Pages 449-455

  Syrjanen S ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CLINICAL OBSERVATION; DISEASE ASSOCIATION; DNA DETERMINATION; DRINKING; EPITHELIUM; GENE EXPRESSION; GENETIC ANALYSIS; GENITAL TRACT CANCER; HUMAN; LARYNX CARCINOMA; LYMPHOID TISSUE; MOUTH CARCINOMA; ONCOGENE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; TONSIL; TONSIL CARCINOMA; TONSILLITIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TONSILLAR NEOPLASMS;

EID: 2442428503     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.008656     Document Type: Review

References (62)

1. Geneser F. Textbook of histology. Copenhagen: Munsgaard, 1986.
2. Brook I. The clinical microbiology of Woldeyer's ring. Otolaryngol Clin North Am 1987;20:259-72.
3. Mellin H, Dahlgren L, Munck-Wikland E, et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002;102:152-8.
4. Mellin H. Human papillomavirus in tonsillar carcinoma. Stockholm, Sweden: Karolinska University Press, 2002.
5. Snijders PJF, Cromme FV, van den Brule AJC, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992;52:845-50.
6. Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000;89:300-4.
7. Gillison ML, Koch WM, Copane RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
8. Mork J, Lie AK, Glottre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-31.
9. Paz IB, Cook N, Odom-Maryon T, et al. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;79:595-604.
10. Barnes L, Johnson JT. Pathologic and clinical considerations in the evaluation of major head and neck specimens resected for cancer. Part I. J Pathol Annu 1986;21:173-250.
11. Franceschi S, Munoz N, Bosch X, et al. Human papillomavirus and cancer of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemial Biomarkers Prev 1996;5:567-75.
12. Syrjänen XJ. HPV infections in lung cancer. J Clin Pathol 2002;55:885-91.
13. Syrjänen KJ. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol 2003;56:174-81.
14. Syrjänen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002;55:721-8.
15. Manual of the international statistical classification of diseases, injuries, and causes of death. Geneva: World Health Organisation, 1979.
16. International statistical classification of diseases and related health problems, 10th revision. Geneva: World Health Organisation, 1993.
17. Frisch M, Hjalgrim H, Bonnerup Jaeger A, et al. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 2000;11:489-95.
18. Frisch M, Goodman MT. Human papillomavirus-associated carcinomas in Hawaii and the mainland. Cancer 2000;88:1464-9.
19. Finnish Cancer Registry (www.cancerregistry.fi).
20. Swedish Cancer Registry (www.sos.se/epc).
21. Beaty MM, Funk GF, Karnell LH, et al. Risk factors for malignancy in adult tonsils. Head Neck 1998;20:399-403.
22. Givens CD Jr, Jahns ME, Cantrell RW. Carcinoma of the tonsil. Analysis of 162 cases. Arch Otolaryngol 1981;107:730-4.
23. Hicks WL Jr, Kuriakose MA, Loree TR, et al. Surgery versus radiation therapy as single-modality treatment of tonsillar fossa carcinoma: the Roswell Park Cancer Institute experience (1971-1991). Laryngoscope 1998;108:1014-19.
24. Bagnardi V, Blangiardo M, La Vecchia C, et al. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001;85:1700-5.
25. Lewin F, Norell SE, Johansson H, et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck. A population-based case-referent study in Sweden. Cancer 1998;82:1367-75.
26. Frisch M, Biggar RJ. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 1999;354:1442-3.
27. Hemminki K, Dong C, Frish M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev 2000;9:433-7.
28. Syrjänen K, Syrjänen S. Papillomavirus infections in human pathology. London: Wiley, 2000.
29. Niedobitek G, Pitteroff S, Herbst H, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 1990;43:918-21.
30. Arndt O, Zeise K, Bauer I, et al. Humane Papillomviren (HPV) vom Typ 6/11 und 16/18 in Plattenepithelkarzinomen des oberen Atmungs-und Verdauungstraktes. Eine In-situ-Hybridisierungsstudie. Laryngorhinootologie 1992;71:500-4.
31. Demetrick D, Inoue M, Lester W, et al. Human papillomavirus type 16 associated with oral squamous cell carcinoma in a cardiac transplant recipient. Cancer 1990;66:1726-31.
32. Swoboda A, Fabrizii V. Tonsillar carcinoma in a renal graft recipient treated with cyclosporine. Clin Nephrol 1993;39:272-4.
33. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989;115:621-5.
34. Ishibashi T, Matsushimo S, Tsunakawa Y, et al. Human papillomavirus DNA in squamous cell carcinoma of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 1990;116:294-8.
35. Bercovich JA, Centena CR, Aguilar OG, et al. Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. J Gen Virol 1991;72:2569-72.
36. Snijders PJF, Steenbergen RDM, Top B, et al. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 1994;75:2769-75.
37. Brachman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992;52:4832-6.
38. Watanabe S, Ogura H, Fukushima K, et al. Comparison of Virapap filter hybridization with polymerase chain reaction and Southern blot hybridization methods for detection of human papillomavirus in tonsillar and pharyngeal cancers. Eur Arch Otorhinoloryngol 1993;250:115-19.
39. Ogura H, Watanabe S, Fukushima K, et al. Human papillomavirus DNA in squamous cell carcinomas of the respiratory and upper digestive tracts. Jpn J Clin Oncol 1993;23:221-5.
40. Lewensohn-Fuchs I, Munck-Wikland E, Berke Z, et al. Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck and esophagus. Anticancer Res 1994;14:1281-5.
41. Brandwein M, Zeitlin J, Nuovo GJ, et al. HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 1994;7:720-7.
42. Turazza E, Lapeña A, Sprovieri O, et al. Low-risk human papillomovirus types 6 and 11 associated with carcinomas of the genital and upper aero-digestive tract. Acta Ostet Gynecol 1997;76:271-6.
43. Andl T, Kahn T, Pfuhl A, et al. Biological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58:5-13.
44. Schwarz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998;90:1626-36.
45. Wilczynski SP, Lin BT, Xie Y, et al. Detection of human papillomavirus DNA and ancoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998;152:145-56.
46. Badaracco G, Venuti A, Morella R, et al. Human papillomavirus in head and neck carcinomas; prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res 2000;20:1301-6.
47. Lopez-Lizarraga E, Sanchez-Carona J, Montoya-Fuentes H, et al. Human papillomavirus in tonsillar and nasopharyngeal carcinoma: isolation of HPV subtype 31. Ear Nose Throat J 2000;79:942-4.
48. Ishiji T, Kawase M, Honda M, et al. Distinctive distribution of human papillomavirus type 16 and type 20 DNA in the tonsillar and the skin carcinomas of a patient with epidermodysplasia verruciformis. Br J Dermatol 2000;143:1005-10.
49. Badaracco G, Venut A, Bartolazzi A, et al. Overexpressian of p53 and bcl-2 proteins and the presence of HPV infection are independent events in head and neck cancer. J Oral Pathol Med 2000;29:173-9.
50. Klussman JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001;92:2875-84.
51. Strome SE, Savva A, Brissett AE, et al. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 2002;8:1093-100.
52. Ringström E, Peters E, Hasegawa, et al. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002;8:3187-92.
53. Kahn T, Turazza E, Ojeda R, et al. Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res 1994;54:1305-12.
54. Snijders PJF, Meijer CJL, van den Brule AJC, et al. Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Gen Virol 1992;73:2059-66.
55. Snijders PJF, van den Brule AJC, Schrijnemakers HFJ, et al. Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6 transcript species which are terminated at different early region poly(A) sites. J Virol 1992;66:3172-8.
56. Dong XP, Stubenrauch F, Beyer-Flinker E, et al. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 1994;58:803-8.
57. Watts KJ, Thompson CH, Cossart YE. Variable oncogene promoter activity of human papillomavirus type cervical cancer isolates from Australia. J Clin Microbiol 2001;39:2009-14.
58. Peitsaro P, Hietanen S, Johansson B, et al. Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 gives rise to an epithelial cell clone with selective growth advantage. Carcinogenesis 2002;6:1057-64.
59. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91.
60. Smith EM, Pignatari SSN, Gray SD, et al. Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatasis using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg 1993;119:554-7.
61. Fukushima K, Ogura H, Watonabe S, et al. Human papillomavirus type 16 DNA detected by the polymerase chain reaction in non-cancer tissues of the head and neck. Eur Arch Otorhinolaryngol 1994;251:109-12.
62. Tominaga S, Fukushima O, Ohama T, et al. Presence of human papillomavirus type 6f in tonsillar condyloma acumicatum and clinically normal tonsillar mucosa. Jpn J Clin Oncol 1996;26:393-7.